Coronary heart disease and all-causes mortality in the multiple risk factor intervention trial: Subgroup findings and comparisons with other trials
References (30)
The Multiple Risk Factor Intervention Trial (MRFIT). II. The model for intervention
Prev. Med.
(1981)- et al.
The Multiple Risk Factor Intervention Trial (MRFIT). VI. Intervention on blood pressure
Prev. Med.
(1981) - et al.
Effect of diet and smoking intervention on the incidence of coronary heart disease: Report from the Oslo Study Group of a randomized trial in healthy men
Lancet
(1981) - et al.
The Multiple Risk Factor Intervention Trial (MRFIT). V. Intervention on smoking
Prev. Med.
(1981) - et al.
The Multiple Risk Factor Intervention Trial (MRFIT). II. The development of the protocol
Prev. Med.
(1981) Covariance analysis of censored survival data
Biometrics
(1974)- et al.
The Multiple Risk Factor Intervention Trial (MRFIT). IV. Intervention on blood lipids
Prev. Med.
(1981) Regression models and life tables (with discussion)
J. Royal Stat. Soc., Series B
(1972)- et al.
The dilemma of ‘mild’ hypertension: Another viewpoint of treatment
JAMA
(1983) Smoking and diet intervention in healthy coronary high risk men: Methods and 5-year follow-up of risk factors in a randomized trial—The Oslo Study
J. Oslo City Hosp.
(1980)
Treatment of mild hypertension with diuretics: The importance of ECG abnormalities in the Oslo Study and in MRFIT
JAMA
Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension
JAMA
The effect of treatment on mortality in “mild” hypertension—Results of the Hypertension Detection and Follow-up Program
New Engl. J. Med.
The effect of antihypertensive drug treatment on mortality in the presence of resting ECG abnormalities at baseline: The HDFP experience
Circulation
The Oslo Study, cardiovascular disease in middle-aged and young Oslo men
Acta Med. Scand. Suppl.
Cited by (28)
A review of research on cigarette smoking in Preventive Medicine in recognition of the journal's 50th anniversary
2022, Preventive MedicineCitation Excerpt :The mean RCR for the 106 articles meeting eligibility criteria was 1.67 (±0.14), which is at the 69th normalized percentile; 64 of these 106 articles (60.38%) had an RCR that exceeded the NIH median 1.0 and 50th normalized percentile, supporting greater that average influence for NIH-supported research in this field (Table 1). These 64 higher impact studies included a body of controlled trials examining innovative psychosocial interventions to promote smoking cessation as part of interventions to reduce multiple risk behaviors in adults with cardiovascular and other smoking-related medical problems (e.g., Cutler et al., 1985; Holme et al., 1985; Orleans et al., 1990) and interventions focused exclusively on smoking cessation during or following medical treatment for other conditions (Dornelas et al., 2000; Hennrikus et al., 2005; Virtanen et al., 2015). Another body of research focused on improving cessation rates among pregnant women including innovations around the use of financial incentives (e.g., Secker-Walker et al., 1998; Ferreira-Borges, 2005; Higgins et al., 2014; Kurti et al., 2020).
Oster rediscovered - Mega-dose folate for symptomatic atherosclerosis
2007, Medical HypothesesIndependent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-Year follow-up for the multiple risk factor intervention trial
2001, Journal of Electrocardiology